161117-88-0

Basic information

• Product Name: CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER
• Synonyms: CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER;tert-butyl 5-nitropyridin-2-ylcarbaMate
• CAS NO: 161117-88-0
• Molecular Formula: C₁₀H₁₃N₃O₄
• Molecular Weight: 239.23
• Mol File: 161117-88-0.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 325.154°C at 760 mmHg
• Flash Point: 150.448°C
• Appearance: /
• Density: 1.304g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.576
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 11.35±0.70(Predicted)
• CAS DataBase Reference: CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER(161117-88-0)
• EPA Substance Registry System: CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER(161117-88-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36-43
• Safety Statements: 26-36/37
• Hazardous Substances Data: 161117-88-0(Hazardous Substances Data)

Usage

General Description

CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER is a chemical compound with the molecular formula C9H12N4O4. It is commonly used as a pesticide and herbicide. CARBAMIC ACID, (5-NITRO-2-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER is a contact and stomach insecticide with both systemic and residual activity. It is also effective against a wide range of pests, including aphids, thrips, beetles, and caterpillars. However, it is important to handle this chemical with caution as it is toxic to aquatic organisms and may have long-lasting effects in the environment.

InChI:InChI=1/C10H13N3O4/c1-10(2,3)17-9(14)12-8-5-4-7(6-11-8)13(15)16/h4-6H,1-3H3,(H,11,12,14)

Upstream product

• 4214-76-0 5-nitro-pyridin-2-ylamine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 4487-50-7 2-amino-4-nitropyridine 

Downstream Products

• 220731-04-4 5-amino-2-tert-butyloxycarbonylaminopyridine 
• 1404086-67-4 7-((5-Amino-3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)methyl)-7H-purin-6-amine 
• 1404086-65-2 9-((5-Amino-3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)methyl)-9H-purin-6-amine 
• 1404085-44-4 tert-Butyl 5-amino-6-(phenylamino)pyridin-2-ylcarbamate 
• 1404085-45-5 tert-Butyl 2-(chloromethyl)-3-phenyl-3H-imidazo[4,5-b]pyridin-5-ylcarbamate 
• 1404085-47-7 tert-butyl 2-((6-amino-9H-purin-9-yl)methyl)-3-phenyl-3H-imidazo[4,5-b]pyridin-5-ylcarbamate 
• 1404085-48-8 tert-butyl 2-((9H-purin-6-ylthio)methyl)-3-phenyl-3H-imidazo[4,5-b]pyridin-5-ylcarbamate 
• 1450620-58-2 tert-butyl (5-(((3S)-3-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-4-(4-(2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl)phenyl)-1-piperazinyl)sulfonyl)-2-pyridinyl)carbamate 
• 1450620-50-4 2-(4-((2S)-4-((6-amino-3-pyridinyl)sulfonyl)-2-((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)-1-piperazinyl)phenyl)-1,1,1,3,3,3-hexafluoro-2-propanol 
• 1450620-73-1 (2S)-2-(4-((2S)-4-((6-amino-3-pyridinyl)sulfonyl)-2-(1-propyn-1-yl)-1-piperazinyl)phenyl)-3,3,3-trifluoro-1,2-propanediol 
• 1450620-75-3 (2R)-2-(4-((2S)-4-((6-amino-3-pyridinyl)sulfonyl)-2-(1-propyn-1-yl)-1-piperazinyl)phenyl)-3,3,3-trifluoro-1,2-propanediol 
• 1450621-40-5 tert-butyl (6-(1-propyn-1-yl)-5-((4-(4-(2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl)phenyl)-1-piperazinyl)sulfonyl)-2-pyridinyl)carbamate 
• 1450621-35-8 2-(4-(4-((6-amino-2-(1-propyn-1-yl)-3-pyridinyl)sulfonyl)-1-piperazinyl)phenyl)-1,1,1,3,3,3-hexafluoro-2-propanol 
• 1450620-78-6 2-(4-((2S)-4-((6-amino-3-pyridinyl)sulfonyl)-2-(1-propyn-1-yl)-1-piperazinyl)phenyl)-3,3,3-trifluoro-1,2-propanediol 

Relevant articles and documents

Discovery of novel heterocyclic factor VIIa inhibitors

Structure-activity relationships and binding mode of novel heterocyclic factor VIIa inhibitors will be described. In these inhibitors, a highly basic 5-amidinoindole moiety has been successfully replaced with a less basic 5-aminopyrrolo[3,2-b]pyridine sca

PLATELET ADP RECEPTOR INHIBITORS

no abstract published

TYK2 INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.